These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5465390)

  • 41. Effects of chlorpromazine, promazine, diethazine, reserpine, hydroxyzine, and morphine upon some mono- and polysynaptic motor reflexes.
    SILVESTRINI B; MAFFII G
    J Pharm Pharmacol; 1959 Apr; 11(4):224-33. PubMed ID: 13642294
    [No Abstract]   [Full Text] [Related]  

  • 42. The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist.
    Palacios JM; Bolliger G; Closse A; Enz A; Gmelin G; Malanowski J
    Eur J Pharmacol; 1986 Jun; 125(1):45-62. PubMed ID: 3732391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pharmacological properties of 3-methyl-3,9-diazabicyclo(3,3,1) nonane derivatives of 2-chlorophenothiazine].
    Medvedev BA; Mashkovskiĭ MD
    Farmakol Toksikol; 1972 Jul; 35(4):401-5. PubMed ID: 5050266
    [No Abstract]   [Full Text] [Related]  

  • 44. Electrocardiographic evaluation of mesoridazine (Serentil).
    Dillenkoffer RL; Gallant DM; Phillips JH
    Curr Ther Res Clin Exp; 1972 Feb; 14(2):71-2. PubMed ID: 4622440
    [No Abstract]   [Full Text] [Related]  

  • 45. [Pharmacological foundations of analgesia].
    Zipf HF; Spechtmeyer H
    Hippokrates; 1969 Aug; 40(15):569-89. PubMed ID: 4390825
    [No Abstract]   [Full Text] [Related]  

  • 46. [General pharmacological properties of methiazinic acid (16091 RP)].
    Julou L; Guyonnet JC; Ducrot R; Bardone MC; Detaille JY; Laffargue B
    Arzneimittelforschung; 1969 Aug; 19(8):1198-206. PubMed ID: 4390179
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacological studies on the central action of novel benzylidene-imidazothiazolone derivatives.
    Kolasa K; Kleinrok Z; Pietrasiewicz T; Czechowska G; Kieć-Kononowicz K; Zejc A
    Pol J Pharmacol Pharm; 1989; 41(4):377-83. PubMed ID: 2576811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pharmacological properties of a potent neurotropic compound from the dibenzothiazepine group.
    Stille G; Ackermann H; Eichenberger E; Lauener H
    Int J Neuropharmacol; 1965 Nov; 4(6):375-91. PubMed ID: 5894258
    [No Abstract]   [Full Text] [Related]  

  • 49. Chemical and pharmacological classification of neuroleptics.
    Janssen PA
    Mod Probl Pharmacopsychiatry; 1970; 5():33-44. PubMed ID: 5535847
    [No Abstract]   [Full Text] [Related]  

  • 50. Modification of rabbit body temperature induced by the simultaneous injection of gonococcus vaccine and various phenothiazine neuroleptics.
    Lechat P; Levassort C
    Pharmacology; 1969; 2(2):100-12. PubMed ID: 4389739
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacological profile of a new psychotherapeutic agent: 4-p-fluorophenyl-5-N(N'-o-methoxyphenyl)piperazinoethyl-4-oxazolin-2-one (LR 511).
    Fregnan GB; Vidali M
    Pharmacology; 1977; 15(6):485-502. PubMed ID: 563604
    [No Abstract]   [Full Text] [Related]  

  • 52. The central action of 5-allyl-5-(beta-hydroxypropyl)-N-phenylbarbituric acid and the corresponding lactone.
    Sieroslawska J; Czarnecki R; Sypniewska M; Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1973; 25(2):113-26. PubMed ID: 4798099
    [No Abstract]   [Full Text] [Related]  

  • 53. [Studies on diazabicycloalkanes. II. Antihistaminic and psychotropic activities of 4-(beta-(10-phenothiazinyl)-ethyl)-1,4-diazabicyclo (4,4,0)-decane and its related compounds].
    Yamada K; Yamazoe H; Tanabe T; Kato H; Kinoshita Y
    Yakugaku Zasshi; 1973 Jul; 93(7):854-60. PubMed ID: 4147240
    [No Abstract]   [Full Text] [Related]  

  • 54. Mesolimbic involvement with behavioural effects indicating antipsychotic activity.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1974 Jun; 27(1):46-58. PubMed ID: 4604756
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmacological studies of a new antitussive, 4-phenyl-l-piperidinecarboxamide (AH 1932).
    Brittain RT; Lees EJ; Spencer PS
    J Pharm Pharmacol; 1968 Jun; 20(6):456-64. PubMed ID: 4386528
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacological properties of a new potential neuroleptic drug oxyprothepin. IV. Antiadrenergic action and influence on brain monoamines.
    Dlabac A; Metys J; Metysová J
    Act Nerv Super (Praha); 1971; 13(3):188-9. PubMed ID: 5113833
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmacological studies on ticlopidine, a new platelet aggregation inhibitor. Part II: General pharmacological properties.
    Akashi A; Hashizume T; Tanaka M; Naka S; Hirohashi M; Kasai Y; Sakurai T; Watanabe K; Tsubokawa M; Kasahara A
    Arzneimittelforschung; 1980; 30(3):415-9. PubMed ID: 7387751
    [No Abstract]   [Full Text] [Related]  

  • 58. [Basic investigations in drug evaluation of CNS-acting drugs. Investigation with regards to drug evaluation of CNS-acting drugs with methamphetamine and variation in body temperature].
    Itabashi H
    Zasshi Tokyo Ika Daigaku; 1969 Jul; 27(4):475-98. PubMed ID: 4392125
    [No Abstract]   [Full Text] [Related]  

  • 59. [Study of the psychotropic effect of analgesics and neuroleptics based on a model of exploratory behavior modified by pain].
    Poshivalov VP
    Biull Eksp Biol Med; 1973 Aug; 76(8):72-5. PubMed ID: 4777691
    [No Abstract]   [Full Text] [Related]  

  • 60. The effect of some phenothiazine derivatives on neuromuscular transmission.
    Sharma VN; Mahawar MM; Barar FS
    Indian J Med Sci; 1965 Oct; 19(10):751-7. PubMed ID: 5848731
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.